Ireland
--:--IST
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Universidade Cesumar (UNICESUMAR) clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Brazil register with Universidade Cesumar (UNICESUMAR) as lead sponsor. Synced 7 Oct 2026
3Current trials
0Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Universidade Cesumar (UNICESUMAR) is the lead sponsor of 3 current clinical trials in our Brazil register. None of its ClinicalTrials.gov trials is recruiting at the moment. All registered phases are Not applicable. The most-studied condition is Obesity & Overweight.

ClinicalTrials.gov trials by status

  • Not yet open267%
  • By invitation133%

Trials by phase

  • Not applicable3100%
01

Clinical trials sponsored by Universidade Cesumar (UNICESUMAR)

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
WB-EMS Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Psychological and Functional Outcomes in Older Adults With Excess Adiposity
NCT07859072 · ClinicalTrials.gov ↗ · Overweight (BMI > 25), Obesity & Overweight, Aging
Not applicable Not yet open 2026-10 Brazil
Multimodal Intervention for Weight Management and Health in the Elderly Population
NCT07820774 · ClinicalTrials.gov ↗ · Obesity & Overweight
Not applicable Not yet open 2026-09 Brazil
VICIA FABA PEPTIDES AND RESISTANCE TRAINING IN THE ELDERLY
NCT07858292 · ClinicalTrials.gov ↗ · Healthy Aging
Not applicable By invitation 2026-11 Brazil

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Universidade Cesumar (UNICESUMAR) trials

4 conditions
Obesity & Overweight2Overweight (BMI > 25)1Aging1Healthy Aging1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Brazil30

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Obesity & Overweight

SponsorTrials
Medipol University4
University College Dublin3
Wageningen University2
Poznan University of Life Sciences2
Hospital das Clínicas de Ribeirão Preto2
Corxel Pharmaceuticals1
The United Bio-Technology (Hengqin)1
Pharmanutra1
Maria Cecilia Hospital1
Jan Kochanowski University1

Sponsors with the most current trials registered for this condition.

05

Questions about Universidade Cesumar (UNICESUMAR) trials

How many clinical trials does Universidade Cesumar (UNICESUMAR) sponsor?

Universidade Cesumar (UNICESUMAR) is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Brazil register, as of the registry sync on 7 October 2026. Completed and withdrawn studies are not counted.

Are Universidade Cesumar (UNICESUMAR) trials recruiting?

Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 7 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.